
Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance.
Danish drugmaker Novo Nordisk said Wednesday that it will drop prices 23% for all doses of Wegovy. The new monthly price of $499, down from $650, takes effect immediately.